Mastery EAQ Ch. 34

A  Softened cervix

B  Strong contractions

C  Decreased pain

D  Midline fundus

A  Renal failure

B  Pulmonary embolism

C  Ovarian failure

D  Abnormal vaginal bleeding

A  Anxiety, Dizziness, Blurred vision

B  Hirsutism, Dizziness,, Increased diuresis

C  Hirsutism, Bradycardia, Increased diuresis

D  Blurred vision, Bradycardia, Increased diuresis

A  During the entire period the patient is taking the antibiotic

B  Until three throat cultures have been negative for the pathogen

C  For at least 1 month after starting the antibiotic

D  For at least 6 weeks, starting at the end of the antibiotic regimen

A  Estradiol

B  Alendronate

C  Methylergonovine

D  Megestrol

A  Calcium gluconate

B  Atropine

C  Protamine sulfate

D  Epinephrine

A  Obtain a prescription for indomethacin.

B  Obtain a prescription for terbutaline.

C  Request a prescription to give calcium gluconate.

D  Decrease the drug dose immediately.

A  Place the patient on her left side.

B  Administer phentolamine mesylate.

C  Immediately discontinue intravenous (IV) fluids.

D  Instruct the patient to bear down and push.

A  Monitor the patient for blurred vision. Administer it before placenta delivery. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

B  Monitor the patient for blurred vision. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

C  Administer it before placenta delivery. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

D  Monitor the patient for blurred vision. Monitor blood pressure during administration. Administer it before placenta delivery. Question the prescription if the patient has liver disease.

A  Hypertension

B  Uterine atony

C  Pelvic inflammatory disease

D  Nausea and vomiting

A  Temperature

B  Blood glucose

C  Blood pressure

D  Uterine contractions

A  Ineffective contractions in a full-term pregnancy

B  Vaginal bleeding at 38 weeks’ gestation

C  Absence of cervical ripening at 42 weeks’ gestation

D  Radiographic confirmation of cephalopelvic disproportion

A  Current tricyclic antidepressant use

B  Use of herbal supplements

C  Low fluid intake

D  Cigarette use

A  Fetal movement, Uterine hyperactivity, Complete blood cell count

B  The patient’s blood pressure and pulse, Complete blood cell count, Uterine hyperactivity

C  Uterine hyperactivity, Fetal heart rate, Complete blood cell count

D  Fetal heart rate, Fetal movement, The patient’s blood pressure and pulse

A  Calcitonin

B  Denosumab

C  Tamoxifen

D  Ibandronate

A  Inform the patient about the benefits and risks of the therapy.

B  Advise the patient to engage in quiet activities.

C  Ask the patient to include soy in her diet.

D  Persuade the patient to start the therapy.

A  “You may need to stop smoking during the therapy.”

B  “The therapy may cause thromboembolic events.”

C  “The treatment is likely to cause endometrial cancer.”

D  “The treatment should be started as soon as possible.”

A  Terbutaline

B  Magnesium sulfate

C  Bed rest and hydration

D  Ritodrine

A  Antibiotic therapy

B  Hypertension

C  Diabetes

D  Anticonvulsant therapy

A  Male condom with spermicidal jelly

B  Norethindrone and ethinyl estradiol

C  Medroxyprogesterone

D  Cervical cap with spermicidal jelly

A  Current smoker

B  Allergy to salmon

C  Breast cancer

D  Joint pain

A  “Obtain a prescription for increasing the bisphosphonate dose.”

B  “Discontinue the calcium supplement.”

C  “Replace the bisphosphonate with calcitonin.”

D  “Space the medications 1 to 2 hours apart.”

A  “Report missed menstrual periods.”

B  “Have a yearly mammogram.”

C  “Have tests for serum cholesterol.”

D  “Perform weight-bearing exercise.”

A  “High progesterone levels inhibit the release of luteinizing hormone.”

B  “Surges of Gn-RH, follicle-stimulating hormone, and luteinizing hormone stimulate ovulation.”

C  “Estrogen levels inhibit the release of follicle-stimulating hormone.”

D  “Decreased Gn-RH suppresses the release of follicle-stimulating hormone.”

A  “I have not experienced any uterine bleeding.”

B  “I no longer experience hot flashes.”

C  “I am no longer experiencing painful intercourse.”

D  “I have seen a great improvement in my sexual desire.”

A  Ferritin

B  Levothyroxine

C  Metformin

D  Amoxicillin

A  Inhibits osteoclast-mediated bone reabsorption

B  Stimulates estrogen receptors on the bone to increase bone density

C  Contains estrogen, which stimulates bone reabsorption

D  Promotes bone absorption of calcium

A  Multivitamin, Atenolol

B  Levothyroxine, Multivitamin

C  Warfarin, Cholestyramine

D  Atenolol, Levothyroxine

A  “This medication will help relieve the bone pain I have from my osteoporosis.”

B  “I will take the medication on an empty stomach and not lie down for 30 minutes.”

C  “I need to take this medication with food to prevent damage to my esophagus.”

D  “I need to decrease my intake of dairy products to prevent hypercalcemia.”

A  Hot flashes, Vertigo, Loss of appetite

B  Chest pain, Hot flashes, Loss of appetite

C  Hot flashes, Loss of appetite, Joint pain

D  Vertigo, Joint pain, Chest pain

A  To treat gestational hypertension

B  To terminate pregnancy

C  To induce cervical ripening

D  To treat pelvic inflammatory disease

A  Consumption of saturated fats

B  Smoking heavily every day

C  Sedentary lifestyle

D  Increased body mass index (BMI)

A  Unopposed estrogen increases the risk of endometrial cancer.

B  Monotherapy with a progestin increases breast cancer risk.

C  Estrogen monotherapy increases the risk of breast cancer.

D  Estradiol with progestin increases the risk of endometrial cancer.

A  Clomiphene

B  Oxytocin

C  Prostaglandin E

D  Terbutaline

A  Medroxyprogesterone

B  Megestrol

C  Estropipate

D  Estrone

A  Loss of hair

B  Yellow undertone to the skin

C  Brown discoloration of face

D  Hot flashes

A  Administer acetaminophen as needed.

B  Assess pulse oximetry continuously.

C  Suggest the patient take aluminum hydroxide with the medication.

D  Monitor the patient’s blood pressure frequently.

A  Oxytocin

B  Dinoprostone

C  Clomiphene

D  Indomethacin

A  Progesterone

B  Clomiphene

C  Choriogonadotropin alfa

D  Ethinyl estradiol

A  Uterine bleeding

B  Weight loss

C  Deep vein thrombosis

D  Dysmenorrhea

A  “The progestin in the regimen will help prevent ovarian cancer.”

B  “Vaginal cancer is prevented by adding progestin to the regimen.”

C  “Endometrial cancer risk can be reduced by adding progestin.”

D  “The progestin in the regimen will help prevent breast cancer.”

A  Interference with the proliferation of the fertilized ovum

B  Elevated progesterone levels inhibiting the release of the luteinizing hormone

C  Diminished endometrial tissue proliferation

D  Inhibition of the release of gonadotropins

A  Follicle-stimulating hormone

B  Luteinizing hormone

C  Antidiuretic hormone

D  Adrenocorticotropic hormone

A  Dysmenorrhea

B  Weight gain

C  Hypertension

D  Thrombophlebitis

A  Dry skin

B  Higher-pitched voice

C  Weight loss

D  Nausea

A  Premature labor

B  Accelerated labor

C  Postpartum hemorrhage

D  Termination of pregnancy

A  Esterified estrogens

B  Medroxyprogesterone

C  Megestrol

D  Alendronate

A  Phase 2

B  Phase 3

C  Phase 1

D  Phase 4

A  Monophasic

B  Biphasic

C  Triphasic

D  Extended-cycle

A  Luteotropic hormone

B  Follicle-stimulating hormone (FSH)

C  Luteinizing hormone (LH)

D  Interstitial cell-stimulating hormone

A  Medroxyprogesterone acetate

B  Megestrol

C  Methylergonovine

D  Indomethacin

A  Oxytocin

B  Terbutaline

C  Methylergonovine

D  Magnesium sulfate

A  Methylergonovine

B  Clomiphene

C  Raloxifene

D  Megestrol

A  Day 3

B  Day 14

C  Day 7

D  Day 21

A  Antidiuretic hormone

B  Luteinizing hormone (LH)

C  Follicle-stimulating hormone (FSH)

D  Adrenocorticotropic hormone

A  The contractions can be fatal to the patient.

B  The patient is ready for delivery.

C  The patient’s blood pressure is stable.

D  The fetal heart rate is stable.

A  Compliance with the fertility drugs

B  Current use of medications for depression

C  Presence of abnormal uterine bleeding

D  Current smoking status

A  Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Ovarian cancer

B  Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events

C  Dementia, Ovarian cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events

D  Dementia, Breast cancer, Ovarian cancer, Cardiovascular disease, Serious cardiovascular events